Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sarcopenia.

J E Morley1, R N Baumgartner, R Roubenoff

  • 1Division of Geriatric Medicine, Saint Louis University School of Medicine, MO 63104, USA.

The Journal of Laboratory and Clinical Medicine
|April 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of protein energy malnutrition in older persons, part I: History, examination, body composition, and screening tools.

Nutrition (Burbank, Los Angeles County, Calif.)·2000
Same author

In the steps of giants: the early geriatrics texts.

Journal of the American Geriatrics Society·2000
Same author

Growth hormone: fountain of youth or death hormone?

Journal of the American Geriatrics Society·1999
Same author

Peripheral steroid sulfatase inhibition potentiates improvement of memory retention for hippocampally administered dehydroepiandrosterone sulfate but not pregnenolone sulfate.

Psychoneuroendocrinology·1999
Same author

Septo-hippocampal drug interactions in post-trial memory processing.

Brain research·1999
Same author

Changes in membrane fatty acids and delta-9 desaturase in senescence accelerated (SAMP8) mouse hippocampus with aging.

Life sciences·1999

Sarcopenia, the age-related loss of muscle mass and strength, contributes to frailty. Decreased physical activity is a key factor in its development, necessitating further research into sarcopenia

Area of Science:

  • Gerontology and Muscle Physiology

Background:

  • Sarcopenia, characterized by age-related loss of muscle mass and strength, is a significant contributor to frailty and functional decline in older adults.
  • Prevalence varies, affecting 8.8% of young-old women to 17.5% of old-old men, with obese sarcopenic individuals (
  • fat frail
  • ) exhibiting poorer outcomes.
  • Pathogenesis involves disproportionate atrophy of type IIa muscle fibers, decreased myosin heavy chain protein synthesis, and motor unit decline.

Framework:

  • Cytokines, including interleukin-1beta, tumor necrosis factor-alpha, and interleukin-6, are implicated in sarcopenia's development.
  • Age-related decline in anabolic hormones such as testosterone, dehydroepiandrosterone, growth hormone, and insulin-like growth factor-I also plays a role.

Implementation:

Related Experiment Videos

  • While the role of age-related physiological anorexia requires further study, decreased physical activity is identified as a primary driver of sarcopenia.
  • Research is needed to fully elucidate the multifactorial pathogenesis of sarcopenia.

    • Implications:

    • Understanding sarcopenia's mechanisms is crucial for developing interventions to combat age-related functional impairment and frailty.
    • Targeting physical activity, hormonal changes, and inflammatory pathways may offer therapeutic strategies.